Efficacy of infliximab in treatment on inflammatory bowel disease and factors affecting the therapeutic effect / 南方医科大学学报
Journal of Southern Medical University
;
(12): 1833-1838, 2013.
Article
Dans Chinois
| WPRIM
| ID: wpr-232690
ABSTRACT
Infliximab has shown its superiority and safety in the treatment of inflammatory bowel disease (IBD) that failed to respond to traditional medical therapy, in refractory cases with obvious adverse reactions, and in "top-down therapy". For standardized and effective management of IBD, experts worldwide have consecutively issued the 2010 European ECCO guide, 2011 London consensus, and 2012 Chinese consensus. In this paper, based on the latest expert consensus worldwide, we reviewed the efficacy of infliximab treatment on IBD and the factors affecting its therapeutic effect.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Agents gastro-intestinaux
/
Maladies inflammatoires intestinales
/
Anti-inflammatoires non stéroïdiens
/
Utilisations thérapeutiques
/
Traitement médicamenteux
/
Infliximab
/
Anticorps monoclonaux
Limites du sujet:
Humains
langue:
Chinois
Texte intégral:
Journal of Southern Medical University
Année:
2013
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS